IMC Chicago
XENE icon

IMC Chicago’s Xenon Pharmaceuticals XENE Stock Holding History

IMC Chicago’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$684K Buy
18,400
+8,500
+86% +$505K ﹤0.01% 4339
2026
Q2 		$598K Sell
9,900
-88,100
-90% -$4.89M ﹤0.01% 4442
2026
Q1 		$5.7M Buy
98,000
+33,400
+52% +$1.54M ﹤0.01% 1680
2025
Q4 		$2.9M Buy
64,600
+39,600
+158% +$1.66M ﹤0.01% 2138
2025
Q3 		$1M Buy
+25,000
New +$881K ﹤0.01% 2707

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

IMC Chicago's XENE Position: Q3 2026 in Review

IMC Chicago sold out of Xenon Pharmaceuticals (XENE) in Q3 2026, closing a stake of 15,083 shares — an estimated $896K sold.

IMC Chicago first reported a position in XENE in Q2 2026 and held it in 1 quarter. The position peaked at $910K in Q2 2026. 142 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • IMC Chicago reported no remaining Xenon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • IMC Chicago sold 15,083 Xenon Pharmaceuticals shares in Q3 2026, an estimated $896K.
  • IMC Chicago first reported a position in Xenon Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • IMC Chicago's Xenon Pharmaceuticals position peaked at $910K in Q2 2026.
  • 142 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.